Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Long-Term Debt Repayments (2016 - 2024)

Conmed's Long-Term Debt Repayments history spans 10 years, with the latest figure at $70.0 million for Q1 2024.

  • For Q1 2024, Long-Term Debt Repayments changed N/A year-over-year to $70.0 million; the TTM value through Dec 2024 reached $70.0 million, changed N/A, while the annual FY2024 figure was $70.0 million, N/A changed from the prior year.
  • Long-Term Debt Repayments reached $70.0 million in Q1 2024 per CNMD's latest filing, up from -$3.3 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $70.0 million in Q1 2024 to a low of -$9.9 million in Q4 2020.
  • Average Long-Term Debt Repayments over 3 years is $10.0 million, with a median of $3.3 million recorded in 2020.
  • The largest YoY upside for Long-Term Debt Repayments was 0.03% in 2020 against a maximum downside of 400.06% in 2020.
  • A 3-year view of Long-Term Debt Repayments shows it stood at -$9.9 million in 2020, then soared by 66.66% to -$3.3 million in 2021, then skyrocketed by 2212.89% to $70.0 million in 2024.
  • Per Business Quant, the three most recent readings for CNMD's Long-Term Debt Repayments are $70.0 million (Q1 2024), -$3.3 million (Q2 2021), and $3.3 million (Q1 2021).